German Medical Equipment Stock News

If you are wondering whether Sartorius is now priced for a comeback or still carries too much risk, its recent share performance gives you a lot to think about. The stock last closed at €238.60, with a 2.4% gain over the last 7 days but declines of 8.2% over 30 days, 3.7% year to date, 2.7% over 1 year, 39.7% over 3 years, and 41.2% over 5 years. Recent news coverage has largely focused on the company in the context of broader sentiment around life sciences suppliers and changing...

Why Verbio’s latest earnings matter for investors Verbio (XTRA:VBK) has just reported second quarter and half year results that show a return to profit in the quarter and higher sales, paired with updated production figures across biodiesel, bioethanol and biomethane. The company posted second quarter sales of €456.52 million with net income of €3.38 million, alongside bioethanol and biomethane volumes for the first half that were above the prior year, while biodiesel production was...

Why Hensoldt’s new cloud partnership matters for the stock Hensoldt (XTRA:HAG) and Schwarz Digits are teaming up to develop sovereign, cloud-enabled defence solutions with AI-supported data fusion and quantum-resistant encryption, aimed at Germany and allied nations that require independent defence cloud infrastructure. See our latest analysis for Hensoldt. Despite a softer 7 day and 30 day share price return, Hensoldt’s €80.1 share price sits on a 90 day share price gain of 14.92%, with 1...

Why Allianz’s new buyback matters for shareholders Allianz (XTRA:ALV) has announced a Board approved share repurchase program of up to €2,500 million, running until December 31, 2026. This event puts capital allocation and shareholder returns in clear focus. See our latest analysis for Allianz. At a share price of €381.5, Allianz has seen a 4.41% 1 month share price return and an 18.90% 1 year total shareholder return. The 3 year total shareholder return of 99.68% signals strong longer term...

If you are wondering whether Dr. Ing. h.c. F. Porsche shares are starting to look appealing at current levels, the key question is how the current price compares with a fair value estimate. The stock last closed at €41.32, with a 2.3% decline over 7 days, a 2.2% decline over 30 days, a 13.2% decline year to date and a 26.4% decline over the past year, while the 3 year return sits at a 60.0% decline. These moves have kept attention on how the market is currently pricing the company, with...

Commerzbank is flagging rising concerns over the new U.S. global tariff regime and its potential impact on EU exports. The bank is highlighting possible knock on effects for European trade conditions and banking activity tied to European U.S. trade flows. The EU has warned that the U.S. measures may breach permitted agreements, increasing uncertainty for companies exposed to cross border trade. XTRA:CBK sits in the middle of this discussion, given its role in financing trade between Europe...

DHL Group’s decision to bring more of its healthcare air cargo operations in-house, including pharma routes between Brussels and Cincinnati, has put Deutsche Post (XTRA:DHL) in sharper focus for investors watching specialised logistics revenue plans. See our latest analysis for Deutsche Post. Healthcare logistics moves such as bringing pharma air cargo in-house sit alongside a 6.74% 1 month share price return and 9.87% 3 month share price return, while the 1 year total shareholder return of...

Fresenius Medical Care has launched its largest ever US product rollout with the 5008X hemodiafiltration machine. The company is planning a broad transition of US patients to the new system, alongside a sharp improvement in profitability. Management is framing 2026 as a transition year, with ongoing investments and adjustments to industry changes. For investors following Fresenius SE KGaA (XTRA:FRE), the 5008X launch comes at a time when the stock trades around €51.1 and has delivered a...

GFT Technologies (XTRA:GFT) is back on investors’ radar as its role in AI, cloud migration, and core banking modernization draws fresh attention, alongside speculation about potential interest from larger consulting groups or private equity buyers. See our latest analysis for GFT Technologies. Despite the current interest around AI and potential corporate interest, the share price tells a more cautious story, with a 30 day share price return of a 33% decline and a 1 year total shareholder...

Siemens Energy and 6K Additive have entered a long term supply agreement to upcycle spent nickel alloy powder into additive manufacturing feedstock. The deal focuses on repurposing nickel alloy waste from Siemens Energy into high quality material for industrial 3D printing. The partnership aims to improve material efficiency and support circular use of critical metals in energy and manufacturing applications. For investors watching XTRA:ENR, this agreement adds a fresh angle to the story...

What triggered the sudden move in Gerresheimer (XTRA:GXI)? Gerresheimer (XTRA:GXI) drew attention after a pre market move of more than 70% on low trading volume, just days ahead of its scheduled earnings release on 26 February 2026. See our latest analysis for Gerresheimer. That sharp pre market swing sits against a weak backdrop, with a 30 day share price return of 31.6% decline and a 1 year total shareholder return of 77.3% decline, suggesting momentum has been fading and market risk...

RWE has recently placed a firm order with Vestas for 92 V236-15.0 MW turbines for the 1,380 MW Norfolk Vanguard West offshore wind project in the UK, following its successful award of a Contract for Difference in Allocation Round 7 and targeting final investment decision in summer 2026 with commissioning in 2029. This contract, alongside KKR acquiring a 50% stake in the Norfolk Vanguard projects, underscores how RWE is advancing capital-light partnerships to expand its offshore wind...

Why HOCHTIEF’s latest earnings and dividend move matter for shareholders HOCHTIEF (XTRA:HOT) has caught investor attention after reporting 2025 results with higher sales and net income, announcing a 26% dividend increase to €6.60 per share, and issuing upgraded operational net profit guidance for 2026. The company reported 2025 sales of €38,236.46m compared with €33,301.27m a year earlier, while net income reached €902.33m versus €775.63m. Basic earnings per share from continuing operations...

E.ON (XTRA:EOAN) shares are in focus after the company reported higher earnings alongside a raised investment plan running through 2030, highlighting its continued push into European energy infrastructure projects. See our latest analysis for E.ON. The share price has moved to €18.74, with a 30-day share price return of 10.56% and a 90-day share price return of 20.71%. The 1-year total shareholder return of 61.14% and 5-year total shareholder return of 173.98% point to momentum that has built...

Mercedes-Benz Group (XTRA:MBG) has backed UK-based autonomous driving company Wayve in its substantial Series D funding round. The collaboration focuses on developing and commercializing self-driving solutions using Wayve's AI-driven "embodied intelligence" platform. Mercedes-Benz joins partners such as Uber and Nissan, aligning its premium automotive brand with emerging autonomous mobility technology. For you as an investor, this ties directly into how Mercedes-Benz is positioning its core...

MTU Aero Engines (XTRA:MTX) reported record results for 2025, according to its latest update. The company announced a substantial dividend increase for shareholders. Management issued an optimistic 2026 outlook, pointing to strong demand and progress in its GTF program. MTU also highlighted ongoing expansion in its maintenance capabilities as part of its growth plans. MTU Aero Engines, listed as XTRA:MTX, is a key supplier in civil aerospace with a focus on engine programs such as the GTF...

Recent performance snapshot for BASF BASF (XTRA:BAS) has been flat over the past day, with a 3.5% decline over the past week, a 6% gain over the past month, and roughly 9.5% over the past 3 months. Over longer periods, the stock shows a 9.1% gain year to date and a 5.6% total return over the past year, alongside a 22.5% total return over 3 years and a 5% total return decline over 5 years. See our latest analysis for BASF. At a share price of €48.87, BASF has paired a 6% 30 day share price...

If you are wondering whether Carl Zeiss Meditec is starting to look like value after a tough run, this article will walk you through what the current share price might be implying. The stock has faced heavy pressure, with returns of a 1.7% decline over 7 days, a 6.4% decline over 30 days, a 33.0% decline year to date and a 52.4% decline over 1 year, plus a 78.4% decline over 3 years and 77.8% over 5 years. Recent coverage has focused on the company as a key player in medical technology and...

Context for Deutsche Telekom’s Recent Share Performance Deutsche Telekom (XTRA:DTE) has drawn investor attention after a strong month, with the share price up about 23%, and a gain of roughly 21% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Deutsche Telekom. That recent 23.1% 1 month share price return, on top of a 19.8% year to date share price return at around €33.32, sits alongside a 3 year total shareholder return of 72.5% and 5 year...

Volkswagen (XTRA:VOW3) has appointed Andreas Mindt as the new Group Head of Design. Mindt succeeds Michael Mauer as part of a generational transition in the company’s top design leadership. The move signals a refreshed approach to design at group level across the Volkswagen brands. For an automaker of Volkswagen’s scale, design is not just about looks; it shapes brand identity, pricing power, and how models stand out in crowded segments. As XTRA:VOW3 continues to compete across combustion,...

Fresenius Medical Care (XTRA:FME) closed out FY 2025 with Q4 revenue of €5.1b and basic EPS of €1.14, as full year trailing twelve month figures showed total revenue of €19.6b and EPS of €3.36. Over the past year, the company has seen quarterly revenue move between about €4.8b and €5.1b, while basic EPS has ranged from €0.52 in Q1 2025 to €1.14 in Q4 2025. This has occurred alongside trailing twelve month net income of €978m, which sits against earlier figures such as €538m at the end of...

SUSS MicroTec SE recently concluded a new syndicated loan agreement worth €115 million with a five-year term and two optional one-year extensions, replacing its prior €56 million facility that was set to expire in October 2026. By more than doubling its syndicated loan capacity with a consortium of renowned European banks, the company has increased its financial flexibility for general corporate needs and refinancing. Next, we’ll examine how this expanded €115 million syndicated loan...

Stock context and recent performance snapshot Dr. Ing. h.c. F. Porsche (XTRA:P911) has stayed on investors’ radar after recent trading, with the share price closing at €41.55 and short term returns mixed across the past week and month. Over the past 3 months the stock shows a negative total return, and the 1 year and 3 year total return figures are also negative. This may prompt you to look more closely at how current pricing compares with the company’s earnings and balance sheet. See our...

Elmos Semiconductor (XTRA:ELG) has put shareholder returns in focus by approving a share buyback of up to €10.0 million and proposing a 50% dividend increase following its preliminary 2025 results. See our latest analysis for Elmos Semiconductor. The buyback and proposed dividend increase arrive after a strong run in the shares, with the share price at €127.6 and a 30 day share price return of 16.21%, while the 1 year total shareholder return stands at 78.42%, indicating strong positive...